Abstract 2710: Depletion of CXCR2-dependent myeloid-derived suppressor cells (MDSCs) overcomes anti-PD-1 resistance in a murine model of LKB1-deficient non-small cell lung cancer (NSCLC) with high mutational load
Rui Li(University of California, Los Angeles), Steven M. Dubinett(University of California, Los Angeles), Ziling Huang(UCLA Health), Raymond J. Lim(University of California, Los Angeles), Michael A. Teitell(University of California, Los Angeles), John D. Minna(Center for Neuro-Oncology), Ramin Salehi‐Rad(University of California, Los Angeles), Linh M. Tran(University of California, Los Angeles), Kostyantyn Krysan(University of California, Los Angeles), David B. Shackelford(University of California, Los Angeles), Bin Liu(University of California, Los Angeles), Zhe Jing(University of California, Los Angeles), Milica Momcilovic(University of California, Los Angeles), Manash K. Paul(University of California, Los Angeles), Stephanie L. Ong(University of California, Los Angeles), Stacy Park(Kaiser Permanente)
Cited by 1
Related Papers
High-throughput oncogene mutation profiling in human cancer
|Nature Genetics|2007|996
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
|Cancer Cell|2021|930
Activating Mutations of the Noonan Syndrome-Associated <b> <i>SHP2/PTPN11</i> </b> Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia
|Cancer Research|2004|512
Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer
|The EMBO Journal|2014|470
Mammalian TAK1 Activates Snf1 Protein Kinase in Yeast and Phosphorylates AMP-activated Protein Kinase in Vitro
|Journal of Biological Chemistry|2006|461